Results 41 to 50 of about 377,194 (138)

MODERN ASPECTS OF HUMAN PAPILLOMAVIRUS VACCINATION

Безопасность и риск фармакотерапии, 2018
Human papillomavirus refers to DNA-containing viruses and infects the skin and mucosal epithelium. One common way is to change the  expression of cellular genes by integrating the viral genome into  cellular DNA.
O. S. Alyautdina, M. A. Darmostukova
doaj   +1 more source

Superstitions on Human Papillomavirus in Africa: A Scoping Review

Public Health Challenges, Volume 5, Issue 2, June 2026.
Africa bears a high burden of HPV‐induced diseases; this scoping review explored how superstitions and cultural beliefs fuel vaccine hesitancy. There are widespread myths and opposition from cultural/religious leaders that drive HPV vaccine hesitancy; targeted and culturally sensitive campaigns/educations are essential to improve vaccine uptake and ...
Jimoh Amzat, Kafayat Aminu, Rita Amarachi Nwebo, Precious Nnannah, Chiamaka Norah Ezeagu, Ganiyat Amzat, Kehinde Kazeem Kanmodi   +6 more
wiley   +1 more source

Fel d 1‐Expressing Plant‐Derived Bioparticle: A Novel Treatment for Cat Allergy

Allergy, Volume 81, Issue 6, Page 2156-2171, June 2026.
This study investigates the allergenicity and immunogenicity profile of a novel plant‐derived Fel d 1 bioparticle (eBP). Fel d 1 eBP promotes immune tolerance by redirecting allergic Th2 responses toward Th1 and IL‐10–producing regulatory pathways, including Bregs.
Janice A. Layhadi, Liliana Cifuentes Gutierrez, Sean T. Keane, William Fulton, Nichell A. Samson, Lily Y. D. Wu, Paulina Filipaviciute, Prista Hikmawati, Oleksandra Fedina, Ana Jimenez‐Gil, Stephen R. Durham, Guy Scadding, Guy Tropper, Louis‐Philippe Vézina, Patrick Colin, Ronald van Ree, Mohamed H. Shamji   +16 more
wiley   +1 more source

Expanding Chemical Space of Nucleic Acid Nanoparticles for Tunable Antiviral‐Like Immunomodulatory Responses and Potent Adjuvant Activity

Advanced Functional Materials, Volume 36, Issue 33, 23 April 2026.
We introduce a nucleic acid nanoparticle (NANP) platform designed to be rrecognized by the human innate immune system in a regulated manner. By changing chemical composition while maintaining constant architectural parameters, we identify key determinants of immunorecognition enabling the rational design of NANPs with tunable immune activation profiles
Martin Panigaj, Hannah S. Newton, Jian Wang, Laxmi Pandey, Yelixza I. Avilla, Phong Nguyen, Morgan Chandler, Justin Halman, Yasmine Radwan, Stephanie Smith, Elijah Edmondson, Simone Difilippantonio, Chelsea Sanders, Bao Tran, Yongmei Zhao, Shaojun Xie, Edward Cedrone, Barry W. Neun, Meni Wanunu, Nikolay V. Dokholyan, Marina A. Dobrovolskaia, Kirill A. Afonin   +21 more
wiley   +1 more source

Vilket vaccin är mest effektivt mot Humant papillomavirus (HPV) -16 och -18, som orsakar livmoderhalscancer - Gardasil eller Cervarix? [PDF]

, 2012
HPV är en grupp av över 100 olika virustyper varav 40 kan infektera könsorganen. Dessa virus orsakar den vanligaste sexuellt överförbara infektionen i Sverige och även i övriga världen.
Hadji, Siper
core   +2 more sources

Biopharmaceuticals for Cancer Treatment: An Update

Cancer Medicine, Volume 15, Issue 4, April 2026.
ABSTRACT Cancer is one of the most debilitating diseases, causing profound physical and psychological impacts on patients. The global number of cancer patients has been steadily rising over the last few decades. The development of effective cancer therapies remains the primary focus in life science research, requiring a precise understanding of ...
Anupom Deb Nath, Yousuf Alam, Afsana Mustak Mim, Maksuda Akter, Mohammad Abbas Gani, Khondaker Muhammad Khairul Alam, Md. Nur Alam   +6 more
wiley   +1 more source

Zelluläre Langzeitimmunantwort auf prophylaktische Humane Papillomavirus (HPV) Impfstoffe [PDF]

, 2012
Infections with human papillomaviruses are among the most common sexually transmitted infections, with peak incidence soon after the onset of sexual activity.
Hepburn Drobnjak, Helena Maria
core   +1 more source

Sustained impact of bivalent HPV immunisation on CIN incidence over two rounds of cervical screening

International Journal of Cancer, Volume 158, Issue 5, Page 1348-1360, 1 March 2026.
What's New? While vaccination against high‐risk HPV infection, the primary cause of cervical malignancy, has demonstrated long‐term effectiveness in clinical trials, real‐life longitudinal data are lacking. Here, the authors present linked long‐term screening data on the effectiveness of bivalent HPV vaccination with a minimum follow‐up of 54 months ...
Timothy J. Palmer, Kimberley Kavanagh, Kate Cuschieri, Ross L. Cameron, Catriona Graham, Allan Wilson, Kirsty Roy   +6 more
wiley   +1 more source

PHARMACOLOGICAL COST-BENEFIT ANALYSIS OF VACCINATION OF ADOLESCENTS BY CERVARIX [PDF]

, 2011
Karcinom vrata maternice u svijetu je drugi po učestalosti u žena. U Hrvatskoj je na osmome mjestu zastupljenosti. Ova vrsta karcinoma je bolest mlađih žena.
Škrgatić, Lana, Josip Juras, Ante Ćorušić, Jozo Blajić, Blajić, Jozo, Pavo Planinić, Dragana Ljubojević-Grgec, Juras, Josip, Magdalena Karadža, Ljubojević-Grgec, Dragana, Karadža, Magdalena, Ćorušić, Ante, Planinić, Pavo, Lana Škrgatić   +13 more
core   +1 more source

Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations [PDF]

Advances in proteomic assay methodologies and genomics have significantly improved our understanding of the blood proteome. Schizophrenia and psychosis risk are linked to polygenic scores for schizophrenia and other mental disorders, as well as to ...
Bearden, CE, Walker, E., Corcoran, C, Barbee, J., Kane, J.M., Mongan, D., Perkins, DO, Toben, C, Li, Q.S., Roth, S, Nunez, A.R., Wannan, CMJ, Paul Amminger, G, Mongan, D, Khadimallah, I., Kahn, R.S., Clark, SR, Upthegrove, R, Pasternak, O, Shah, J.L., Billah, T., Martin, AR, Bouix, S, Bearden, C.E., Barbee, J, Khadimallah, I, Walker, E, Martin, A.R., McGorry, PD, Wolf, DH, Li, QS, Do, KQ, Clark, S.R., Do, K.Q., Cerrato, F., Nelson, B., Bleggi, RS, Jeffries, CD, Phassouliotis, C., McGorry, P.D., Calkins, M.E., Shenton, M.E., Shah, JL, Anticevic, A, Nunez, AR, Anticevic, A., Winter-van Rossum, I., Cerrato, F, Bouix, S., Woods, SW, Jeffries, C.D., Shenton, ME, Klauser, P, Billah, T, Cotter, D, Cotter, D., Wolf, D.H., Corcoran, C., Kane, JM, Klauser, P., Calkins, ME, Nelson, B, Wray, N.R., Winter-van Rossum, I, Woods, S.W., Ellman, LM, Perkins, D.O., Upthegrove, R., Roth, S., Phassouliotis, C, Bleggi, R.S., Ellman, L.M., Pasternak, O., Toben, C., Wray, NR, Paul Amminger, G., Kahn, RS   +76 more
core   +1 more source